Cyprumed GmbH

Oral tablet formulation platform that makes therapeutic peptides (macrocyclic peptides, miniproteins, acylated peptides) orally bioavailable, using scalable, cost‑efficient, easy‑to‑manufacture tablet technology. Delivers regulatory‑compliant tablet formulations based on approved excipients for pharmaceutical companies.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading